CEO & Co-Founder @ SEQSTER | Global HealthTech Leader & Speaker | Life Sciences and Healthcare Innovator
Super Exciting news! The FDA just approved Eli Lilly and Company‘s 💊 #Donanemab (Kisunla) for Alzheimer’s, joining Eisai US and Biogen‘s 💊#Leqembi in the fight. SEQSTER’s Operating System powers tracking treatment efficacy, personalizing care, and bridging #HealthData gaps for patients and caregivers. Together, we can make every data point count! SEQSTER Gates Ventures Alzheimer's Disease Data Initiative UsAgainstAlzheimer's Global Alzheimer's Platform Foundation CEOi - Global CEO Initiative on Alzheimer's Disease Davos Alzheimer's Collaborative #DigitalHealth #AlzheimersDisease #FDAApproval #HealthcareInnovation #SEQSTER #PatientData #Caregivers #MedicalBreakthrough https://lnkd.in/gpJucnHH